Literature DB >> 16791114

Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.

Andrea Giacometti1, Oscar Cirioni, Roberto Ghiselli, Federico Mocchegiani, Carmela Silvestri, Fiorenza Orlando, Wojciech Kamysz, Alberto Licci, Elzbieta Kamysz, Jerzy Lukasiak, Vittorio Saba, Giorgio Scalise.   

Abstract

OBJECTIVE: To investigate the efficacy of amphibian antimicrobial peptides in preventing bacterial translocation and neutralizing endotoxins in bile duct-ligated rats.
DESIGN: Prospective, randomized, controlled animal study.
SETTING: Research laboratory in a university hospital.
SUBJECTS: Adult male Wistar rats.
INTERVENTIONS: Adult male Wistar rats underwent sham operation or bile duct ligation (BDL). Eight groups were studied: sham operation with saline treatment, sham operation with 120 mg/kg tazobactam-piperacillin, sham operation with 2 mg/kg uperin 3.6, sham operation with 2 mg/kg magainin2, BDL with saline treatment, BDL with 120 mg/kg tazobactam-piperacillin, BDL with 2 mg/kg uperin 3.6, and BDL with 2 mg/kg magainin2.
MEASUREMENTS AND MAIN RESULTS: Main outcome measures were: endotoxin and tumor necrosis factor-alpha concentrations in plasma and evidence of bacterial translocation in blood, peritoneum, liver, and mesenteric lymph nodes. Endotoxin and tumor necrosis factor-alpha plasma levels were significantly higher in BDL rats compared with sham-operated animals. All amphibian peptides achieved a significant reduction of plasma endotoxin and tumor necrosis factor-alpha concentration when compared with saline- and tazobactam-piperacillin-treated groups. On the other hand, both tazobactam-piperacillin and peptides significantly reduced bacterial growth compared with the control. Tazobactam-piperacillin and magainin2 exerted the maximal inhibition of bacterial growth.
CONCLUSION: In conclusion, because of their multifunctional properties, amphibian peptides could be interesting compounds to inhibit bacterial translocation and endotoxin release in obstructive jaundice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16791114     DOI: 10.1097/01.CCM.0000231879.11963.EB

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

Review 1.  Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.

Authors:  Derek S Wheeler; Basilia Zingarelli; William J Wheeler; Hector R Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2009-06

2.  Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.

Authors:  Oscar Cirioni; Roberto Ghiselli; Carmela Silvestri; Wojciech Kamysz; Fiorenza Orlando; Alessandra Riva; Elzbieta Kamysz; Sefora Castelletti; Marco Rocchi; Vittorio Saba; Giorgio Scalise; Andrea Giacometti
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191

3.  Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction.

Authors:  Mohammad Mehdi Ommati; Omid Farshad; Hossein Niknahad; Khadijeh Mousavi; Marjan Moein; Negar Azarpira; Hamidreza Mohammadi; Akram Jamshidzadeh; Reza Heidari
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.